Luther King Capital Management (LKCM)
HZNP

Luther King Capital Management (LKCM)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,434
Closed -$1.02M – 597
2022
Q3 		$1.02M Sell
16,434
-40,492
-71% -$2.83M 0.01% 375
2022
Q2 		$4.54M Buy
56,926
+42,201
+287% +$4M 0.03% 192
2022
Q1 		$1.55M Buy
14,725
+4,695
+47% +$458K 0.01% 339
2021
Q4 		$1.08M Buy
10,030
+370
+4% +$40.4K ﹤0.01% 401
2021
Q3 		$1.06M Sell
9,660
-585
-6% -$60.7K 0.01% 402
2021
Q2 		$959K Sell
10,245
-225
-2% -$20.7K ﹤0.01% 429
2021
Q1 		$964K Hold
10,470
– – 0.01% 395
2020
Q4 		$766K Sell
10,470
-2,455
-19% -$182K ﹤0.01% 402
2020
Q3 		$1M Sell
12,925
-2,375
-16% -$163K 0.01% 330
2020
Q2 		$850K Sell
15,300
-112,140
-88% -$4.8M 0.01% 340
2020
Q1 		$3.77M Sell
127,440
-14,780
-10% -$500K 0.03% 176
2019
Q4 		$5.15M Sell
142,220
-245
-0.2% -$7.51K 0.03% 179
2019
Q3 		$3.88M Buy
142,465
+22,780
+19% +$589K 0.03% 197
2019
Q2 		$2.88M Buy
119,685
+37,675
+46% +$956K 0.02% 229
2019
Q1 		$2.17M Buy
+82,010
New +$1.94M 0.02% 258

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Luther King Capital Management (LKCM)'s HZNP Position: Q4 2022 in Review

Luther King Capital Management (LKCM) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 16,434 shares — an estimated $1.02M sold.

Luther King Capital Management (LKCM) first reported a position in HZNP in Q1 2019 and held it in 15 quarters. The position peaked at $5.15M in Q4 2019. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Luther King Capital Management (LKCM) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 16,434 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.02M.
  • Luther King Capital Management (LKCM) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 15 quarters.
  • Luther King Capital Management (LKCM)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.15M in Q4 2019.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q4 2022, filed 13 Feb 2023.